Literature DB >> 15132946

Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease.

R K Rao1, A Seth, P Sheth.   

Abstract

A significant body of evidence indicates that endotoxemia and endotoxin-mediated hepatocellular damage play a crucial role in the pathogenesis of alcoholic liver disease. A close correlation between endotoxemia and the severity of alcohol-induced liver injury is supported by a number of clinical and experimental studies. Elevated intestinal permeability appears to be the major factor involved in the mechanism of alcoholic endotoxemia and the pathogenesis of alcoholic liver disease. Ethanol and its metabolic derivatives, acetaldehyde in particular, alter intracellular signal-transduction pathways leading to the disruption of epithelial tight junctions and an increase in paracellular permeability to macromolecules. Studies addressing the mechanisms of such epithelial disruption and the protective factors that prevent ethanol and acetaldehyde-mediated disruption of epithelial tight junctions are critically important in the investigations toward the search of preventive and therapeutic strategies for alcoholic liver disease.

Entities:  

Mesh:

Year:  2004        PMID: 15132946     DOI: 10.1152/ajpgi.00006.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  131 in total

1.  Estrogen suppresses heptatic IκB expression during short-term alcohol exposure.

Authors:  Eric G Lee; Bethany M Mickle-Kawar; Lester A Reinke; Randle M Gallucci
Journal:  Inflamm Res       Date:  2012-06-06       Impact factor: 4.575

Review 2.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

3.  Gut region-dependent alterations of nitrergic myenteric neurons after chronic alcohol consumption.

Authors:  Mária Bagyánszki; Nikolett Bódi
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

4.  ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice.

Authors:  Kamaljit K Chaudhry; Geetha Samak; Pradeep K Shukla; Hina Mir; Ruchika Gangwar; Bhargavi Manda; Toyohi Isse; Toshihiro Kawamoto; Mikko Salaspuro; Pertti Kaihovaara; Paula Dietrich; Ioannis Dragatsis; Laura E Nagy; Radha Krishna Rao
Journal:  Alcohol Clin Exp Res       Date:  2015-07-14       Impact factor: 3.455

5.  Lactic acid bacteria prevent alcohol-induced steatohepatitis in rats by acting on the pathways of alcohol metabolism.

Authors:  Liu Qing; Tailing Wang
Journal:  Clin Exp Med       Date:  2008-09-24       Impact factor: 3.984

6.  Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Gavin E Arteel; K Cameron Falkner; Shirish S Barve; Craig J McClain
Journal:  Alcohol       Date:  2013-02-26       Impact factor: 2.405

7.  Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism.

Authors:  Mitzi Dunagan; Kamaljit Chaudhry; Geetha Samak; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

8.  Alcohol, burn injury, and the intestine.

Authors:  Mashkoor A Choudhry; Irshad H Chaudry
Journal:  J Emerg Trauma Shock       Date:  2008-07

9.  Elevated endotoxin levels in non-alcoholic fatty liver disease.

Authors:  Alison L Harte; Nancy F da Silva; Steven J Creely; Kirsty C McGee; Thomas Billyard; Elham M Youssef-Elabd; Gyanendra Tripathi; Esmat Ashour; Mohga S Abdalla; Hayat M Sharada; Ashraf I Amin; Alastair D Burt; Sudhesh Kumar; Christopher P Day; Philip G McTernan
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

10.  Toll-like receptors in the pathogenesis of alcoholic liver disease.

Authors:  Jan Petrasek; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterol Res Pract       Date:  2010-08-17       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.